These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 24053208

  • 1. Recurrent or refractory primary central nervous lymphoma: therapeutic considerations.
    Dahiya S, Murphy ES, Chao ST, Stevens GH, Peereboom DM, Ahluwalia MS.
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1109-19. PubMed ID: 24053208
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
    Reni M, Ferreri AJ.
    Ann Hematol; 2001 Sep; 80 Suppl 3():B113-7. PubMed ID: 11757691
    [Abstract] [Full Text] [Related]

  • 3. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
    Patel MP, Kirkpatrick JP, Johnson MO, Healy P, Herndon JE, Lipp ES, Miller ES, Desjardins A, Randazzo D, Friedman HS, Ashley DM, Peters KB.
    J Neurooncol; 2020 Apr; 147(2):477-483. PubMed ID: 32140975
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM.
    J Clin Oncol; 2003 Nov 15; 21(22):4151-6. PubMed ID: 14615443
    [Abstract] [Full Text] [Related]

  • 8. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
    Kawamura T, Koga S, Okamoto M, Kanno T, Iwamura H.
    Radiat Med; 2001 Nov 15; 19(3):145-9. PubMed ID: 11467381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT.
    Clin Cancer Res; 2004 Sep 01; 10(17):5643-6. PubMed ID: 15355887
    [Abstract] [Full Text] [Related]

  • 11. Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience.
    Xie H, Dahiya S, Murphy ES, Chao ST, Suh JH, Stevens GH, Peereboom DM, Ahluwalia MS.
    Anticancer Res; 2013 Aug 01; 33(8):3251-8. PubMed ID: 23898087
    [Abstract] [Full Text] [Related]

  • 12. Primary central nervous system lymphoma.
    Batchelor TT.
    Hematology Am Soc Hematol Educ Program; 2016 Dec 02; 2016(1):379-385. PubMed ID: 27913504
    [Abstract] [Full Text] [Related]

  • 13. Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
    Raizer JJ, Rademaker A, Evens AM, Rice L, Schwartz M, Chandler JP, Getch CC, Tellez C, Grimm SA.
    Cancer; 2012 Aug 01; 118(15):3743-8. PubMed ID: 22179954
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
    Provencher S, Ferlay C, Alaoui-Slimani K, Devidas A, Lepretre S, de Prijck B, Sebban C, de la Fouchardiere A, Chassagne-Clement C, Ketterer N, Thyss A, Delannoy A, Tilly H, Biron P, Blay JY, Ghesquières H.
    Hematol Oncol; 2011 Mar 01; 29(1):10-6. PubMed ID: 21381074
    [Abstract] [Full Text] [Related]

  • 15. Primary central nervous system lymphoma causing multiple spinal cord compression and carcinomatous meningitis in a 6-year-old: a case report.
    Quadri SA, Sobani ZA, Enam SA, Enam K, Ashraf MS.
    J Pediatr Hematol Oncol; 2011 May 01; 33(4):312-5. PubMed ID: 21464767
    [Abstract] [Full Text] [Related]

  • 16. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
    Selch MT, Shimizu KT, De Salles AF, Sutton C, Parker RG.
    Am J Clin Oncol; 1994 Aug 01; 17(4):286-93. PubMed ID: 8048389
    [Abstract] [Full Text] [Related]

  • 17. Second-line treatment for primary central nervous system lymphoma.
    Reni M, Ferreri AJ, Villa E.
    Br J Cancer; 1999 Feb 01; 79(3-4):530-4. PubMed ID: 10027325
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma.
    Du S, Fu DB, A Bota D, Kong XT.
    CNS Oncol; 2024 Jun 06; 13(1):2345579. PubMed ID: 38722227
    [Abstract] [Full Text] [Related]

  • 20. Primary central nervous system lymphoma.
    Schaff LR, Grommes C.
    Blood; 2022 Sep 01; 140(9):971-979. PubMed ID: 34699590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.